+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Paracetamol IV Market Research Report by Indication (Pain and Pyrexia/Fever), Application, End-use, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 230 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5666251
UP TO OFF until Mar 31st 2023
The Global Paracetamol IV Market size was estimated at USD 878.46 million in 2022, USD 940.79 million in 2023, and is projected to grow at a CAGR of 7.57% to reach USD 1,575.45 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Paracetamol IV Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Paracetamol IV Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Paracetamol IV Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Paracetamol IV Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Paracetamol IV Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Indication, the market is studied across Pain and Pyrexia/Fever.
  • Based on Application, the market is studied across Non-surgical and Surgical.
  • Based on End-use, the market is studied across Clinics and Hospitals.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Paracetamol IV Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Paracetamol IV Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Paracetamol IV Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Paracetamol IV Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Paracetamol IV Market, including Aurobindo Pharma Ltd., Biological E. Limited, Cfl Pharmaceuticals Limited, Changshu Huagang Pharmaceuticals Co., Ltd., Dr. Reddy's Laboratories Ltd., Geno Pharmaceuticals Private Limited, Hebei Jiheng Pharmaceutical Co.,Ltd., Huzhou Konch Pharmaceutical Co., Ltd., Lupin Pharmaceuticals, Inc., Mallinckrodt PLC, Novartis AG, Sanofi S.A., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and Zhejiang Kangle Pharmaceutical Co., Ltd..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Paracetamol IV Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Paracetamol IV Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Paracetamol IV Market?
4. What is the competitive strategic window for opportunities in the Global Paracetamol IV Market?
5. What are the technology trends and regulatory frameworks in the Global Paracetamol IV Market?
6. What is the market share of the leading vendors in the Global Paracetamol IV Market?
7. What modes and strategic moves are considered suitable for entering the Global Paracetamol IV Market?
Frequently Asked Questions about the Global Paracetamol IV Market

What is the estimated value of the Global Paracetamol IV Market?

The Global Paracetamol IV Market was estimated to be valued at $878.46 Million in 2022.

What is the growth rate of the Global Paracetamol IV Market?

The growth rate of the Global Paracetamol IV Market is 7.5%, with an estimated value of $1575.45 Million by 2030.

What is the forecasted size of the Global Paracetamol IV Market?

The Global Paracetamol IV Market is estimated to be worth $1575.45 Million by 2030.

Who are the key companies in the Global Paracetamol IV Market?

Key companies in the Global Paracetamol IV Market include Aurobindo Pharma Ltd., Biological E. Limited, Cfl Pharmaceuticals Limited, Changshu Huagang Pharmaceuticals Co., Ltd., Dr. Reddy's Laboratories Ltd., Geno Pharmaceuticals Private Limited, Hebei Jiheng Pharmaceutical Co.,Ltd., Huzhou Konch Pharmaceutical Co., Ltd. and Mallinckrodt PLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of indicative diseases and conditions
5.1.1.2. Increasing use of paracetamol IV in relieving fever in post-surgical procedures
5.1.1.3. Enhanced usage of acetaminophen to reduce the dependence on opioids for pain management
5.1.2. Restraints
5.1.2.1. Availability of multiple generic products
5.1.3. Opportunities
5.1.3.1. Government initiatives and rising research and development activities
5.1.3.2. Use of paracetamol IV in combination with non-steroidal anti-inflammatory drugs (NSAID) and narcotics
5.1.4. Challenges
5.1.4.1. Lack of experienced healthcare professionals
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Paracetamol IV Market, by Indication
6.1. Introduction
6.2. Pain
6.3. Pyrexia/Fever

7. Paracetamol IV Market, by Application
7.1. Introduction
7.2. Non-surgical
7.3. Surgical

8. Paracetamol IV Market, by End-use
8.1. Introduction
8.2. Clinics
8.3. Hospitals

9. Americas Paracetamol IV Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Paracetamol IV Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Paracetamol IV Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Product Portfolio Analysis, By Key Player
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Aurobindo Pharma Ltd.
13.2. Biological E. Limited
13.3. Cfl Pharmaceuticals Limited
13.4. Changshu Huagang Pharmaceuticals Co., Ltd.
13.5. Dr. Reddy's Laboratories Ltd.
13.6. Geno Pharmaceuticals Private Limited
13.7. Hebei Jiheng Pharmaceutical Co.,Ltd.
13.8. Huzhou Konch Pharmaceutical Co., Ltd.
13.9. Lupin Pharmaceuticals, Inc.
13.10. Mallinckrodt PLC
13.11. Novartis AG
13.12. Sanofi S.A.
13.13. Sun Pharmaceutical Industries Limited
13.14. Teva Pharmaceutical Industries Ltd.
13.15. Zhejiang Kangle Pharmaceutical Co., Ltd.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL PARACETAMOL IV MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PARACETAMOL IV MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PARACETAMOL IV MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL PARACETAMOL IV MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PARACETAMOL IV MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PARACETAMOL IV MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL PARACETAMOL IV MARKET DYNAMICS
FIGURE 11. GLOBAL PARACETAMOL IV MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL PARACETAMOL IV MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 13. GLOBAL PARACETAMOL IV MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL PARACETAMOL IV MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2030
FIGURE 15. GLOBAL PARACETAMOL IV MARKET SIZE, BY PAIN, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL PARACETAMOL IV MARKET SIZE, BY PYREXIA/FEVER, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 18. GLOBAL PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL PARACETAMOL IV MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 20. GLOBAL PARACETAMOL IV MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
FIGURE 21. GLOBAL PARACETAMOL IV MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL PARACETAMOL IV MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 23. GLOBAL PARACETAMOL IV MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 24. GLOBAL PARACETAMOL IV MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USE, 2030
FIGURE 25. GLOBAL PARACETAMOL IV MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
FIGURE 26. GLOBAL PARACETAMOL IV MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 27. AMERICAS PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 28. AMERICAS PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 29. AMERICAS PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 30. AMERICAS PARACETAMOL IV MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 31. ARGENTINA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 32. BRAZIL PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. CANADA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 34. MEXICO PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 35. UNITED STATES PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 36. UNITED STATES PARACETAMOL IV MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 37. UNITED STATES PARACETAMOL IV MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 38. UNITED STATES PARACETAMOL IV MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 39. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 40. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 41. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 42. ASIA-PACIFIC PARACETAMOL IV MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 43. AUSTRALIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. CHINA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. INDIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. INDONESIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. JAPAN PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. MALAYSIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. PHILIPPINES PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. SINGAPORE PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. SOUTH KOREA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. TAIWAN PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. THAILAND PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. VIETNAM PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 59. DENMARK PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. EGYPT PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. FINLAND PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. FRANCE PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. GERMANY PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. ISRAEL PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. ITALY PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. NETHERLANDS PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. NIGERIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. NORWAY PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. POLAND PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. QATAR PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. RUSSIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. SAUDI ARABIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. SOUTH AFRICA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. SPAIN PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. SWEDEN PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. SWITZERLAND PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. TURKEY PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. UNITED ARAB EMIRATES PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. UNITED KINGDOM PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. GLOBAL PARACETAMOL IV MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 81. GLOBAL PARACETAMOL IV MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 82. GLOBAL PARACETAMOL IV MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL PARACETAMOL IV MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PARACETAMOL IV MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PARACETAMOL IV MARKET SIZE, BY PAIN, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PARACETAMOL IV MARKET SIZE, BY PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PARACETAMOL IV MARKET SIZE, BY PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PARACETAMOL IV MARKET SIZE, BY PYREXIA/FEVER, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PARACETAMOL IV MARKET SIZE, BY PYREXIA/FEVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PARACETAMOL IV MARKET SIZE, BY PYREXIA/FEVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PARACETAMOL IV MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PARACETAMOL IV MARKET SIZE, BY NON-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PARACETAMOL IV MARKET SIZE, BY NON-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PARACETAMOL IV MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PARACETAMOL IV MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PARACETAMOL IV MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PARACETAMOL IV MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PARACETAMOL IV MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PARACETAMOL IV MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PARACETAMOL IV MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PARACETAMOL IV MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PARACETAMOL IV MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 40. CANADA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 41. CANADA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. MEXICO PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES PARACETAMOL IV MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. CHINA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 63. CHINA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. CHINA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. CHINA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. INDIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 67. INDIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. INDIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. INDIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. JAPAN PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. JAPAN PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. THAILAND PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. THAILAND PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. DENMARK PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. DENMARK PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 117. EGYPT PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. EGYPT PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. FINLAND PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. FINLAND PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. FRANCE PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. FRANCE PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. GERMANY PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. ITALY PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 136. ITALY PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. ITALY PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. ITALY PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. NORWAY PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. NORWAY PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 151. POLAND PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 152. POLAND PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 153. POLAND PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. POLAND PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 155. QATAR PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 156. QATAR PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 157. QATAR PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. QATAR PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 173. SPAIN PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SPAIN PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. TURKEY PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. TURKEY PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 195. GLOBAL PARACETAMOL IV MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 196. GLOBAL PARACETAMOL IV MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 197. GLOBAL PARACETAMOL IV MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 198. GLOBAL PARACETAMOL IV MARKET RANKING, BY KEY PLAYER, 2022
TABLE 199. GLOBAL PARACETAMOL IV MARKET SHARE, BY KEY PLAYER, 2022
TABLE 200. GLOBAL PARACETAMOL IV MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 201. GLOBAL PARACETAMOL IV MARKET MERGER & ACQUISITION
TABLE 202. GLOBAL PARACETAMOL IV MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 203. GLOBAL PARACETAMOL IV MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 204. GLOBAL PARACETAMOL IV MARKET INVESTMENT & FUNDING
TABLE 205. GLOBAL PARACETAMOL IV MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 206. GLOBAL PARACETAMOL IV MARKET: LICENSE & PRICING

Companies Mentioned

  • Aurobindo Pharma Ltd.
  • Biological E. Limited
  • Cfl Pharmaceuticals Limited
  • Changshu Huagang Pharmaceuticals Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Geno Pharmaceuticals Private Limited
  • Hebei Jiheng Pharmaceutical Co.,Ltd.
  • Huzhou Konch Pharmaceutical Co., Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Mallinckrodt PLC
  • Novartis AG
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Zhejiang Kangle Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...